Literature DB >> 24297655

Circadian disruption and cancer risk: a new concept of stromal niche (review).

Hiroto Izumi1, Keyong Wang2, Yasuo Morimoto1, Yasuyuki Sasaguri3, Kimitoshi Kohno4.   

Abstract

Circadian rhythms regulate a variety of physiological functions. Epidemiological evidence indicates that disruption of these circadian rhythms might be linked to cancer. In general, imbalances in homeostasis, such as immune and hormonal dysfunctions, are thought to be involved in cancer development. The results of a recent study suggested that circadian disruption may induce stromal changes associated with cancer risk, highlighting the importance of the cancer stem cell niche for protecting cancer cells. Current research provides new concepts and clarification regarding the function of the tumor niche, and the new concept of a stromal niche may help us to understand the additional functions of both cancer-associated fibroblasts and the extracellular matrix. In this review, we summarize our current knowledge regarding the role of circadian rhythms in cancer risk and the relevance of the stromal niche in cancer cell survival and progression.

Entities:  

Mesh:

Year:  2013        PMID: 24297655     DOI: 10.3892/ijo.2013.2201

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Chronotype, social jet lag, sleep debt and food timing in inflammatory bowel disease.

Authors:  Prachi S Chakradeo; Ali Keshavarzian; Shubha Singh; Akram E Dera; James Philip G Esteban; Alice A Lee; Helen J Burgess; Louis Fogg; Garth R Swanson
Journal:  Sleep Med       Date:  2018-08-17       Impact factor: 3.492

2.  Rhyme and reason: the role of circadian rhythms in skin and its implications for physicians.

Authors:  Kavita Beri; Sandy Saul Milgraum
Journal:  Future Sci OA       Date:  2016-04-06

3.  Psychometric Testing of a Food Timing Questionnaire and Food Timing Screener.

Authors:  Prachi Chakradeo; Heather E Rasmussen; Garth R Swanson; Barbara Swanson; Louis F Fogg; Faraz Bishehsari; Helen J Burgess; Ali Keshavarzian
Journal:  Curr Dev Nutr       Date:  2021-12-16

Review 4.  Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer Chemotherapy.

Authors:  Kimitoshi Kohno; Ke-Yong Wang; Mayu Takahashi; Tomoko Kurita; Yoichiro Yoshida; Masakazu Hirakawa; Yoshikazu Harada; Akihiro Kuma; Hiroto Izumi; Shinji Matsumoto
Journal:  Int J Mol Sci       Date:  2015-08-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.